Why is the FDA Banning Epitalon?
The medical establishment calls it “regulatory oversight.” Biohackers call it a war on longevity. At the center of this battle […]
Regulatory News
CJC-1295 & Ipamorelin for GLP-1 Fatigue
Keystone Recomposition Protocol Series.
FDA Peptide Ban: The July Compounding Hearings Update
The battle for regenerative medicine and health choice freedom reaches a critical turning point. On July 23–24, 2026, the FDA’s
Retatrutide Phase 3 Data: The Most Powerful GLP-1 Ever
Keystone Recomposition Protocol Series.